Author

Y. C. Bartsch

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Fasano· 2 shared A. G. Edlow· 2 shared L. M. Yonker· 2 shared A. B. Balazs· 1 shared A. Galit· 1 shared A. L. K. Gonye· 1 shared B. Boribong· 1 shared B. P. Boribong· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Fasano

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neutrophil Profiles of Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children

B. P. Boribong, T. J. LaSalle, Y. C. Bartsch, F. Ellett, M. E. Loiselle, J. P. Davis, A. L. K. Gonye, S. Hajizadeh, J. Kreuzer, S. Pillai, W. Haas, A. G. Edlow, A. Fasano, G. Alter, D. Irimia, , L. M. Yonker

The paper identifies neutrophil activation and NET formation in MIS-C linked to SARS-CoV-2 immune complexes, differing from acute pediatric COVID-19.

bioRxiv · Dec 18, 2021Immunology

Comprehensive antibody profiling of mRNA vaccination in children

Y. C. Bartsch, K. J. St Denis, P. Kaplonek, J. Kang, E. C. Lam, M. D. Burns, E. J. Farkas, J. Davis, B. Boribong, A. G. Edlow, A. Fasano, W. Shreffler, D. Zavadska, M. Johnson, D. Goldblatt, , A. Galit

This study compares humoral immune responses to mRNA vaccines in children aged 6-11 years, finding that a 100g dose elicits robust and dose-dependent cross-VOC antibody responses with preserved functional immunity.

bioRxiv · Oct 7, 2021 · PreprintImmunology